Correlation Between Kiora Pharmaceuticals and Hepion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Kiora Pharmaceuticals and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiora Pharmaceuticals and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiora Pharmaceuticals and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Kiora Pharmaceuticals and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiora Pharmaceuticals with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiora Pharmaceuticals and Hepion Pharmaceuticals.
Diversification Opportunities for Kiora Pharmaceuticals and Hepion Pharmaceuticals
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Kiora and Hepion is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Kiora Pharmaceuticals and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Kiora Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiora Pharmaceuticals are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Kiora Pharmaceuticals i.e., Kiora Pharmaceuticals and Hepion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Kiora Pharmaceuticals and Hepion Pharmaceuticals
Given the investment horizon of 90 days Kiora Pharmaceuticals is expected to under-perform the Hepion Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Kiora Pharmaceuticals is 1.1 times less risky than Hepion Pharmaceuticals. The stock trades about -0.04 of its potential returns per unit of risk. The Hepion Pharmaceuticals is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 69.00 in Hepion Pharmaceuticals on August 23, 2024 and sell it today you would earn a total of 0.00 from holding Hepion Pharmaceuticals or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kiora Pharmaceuticals vs. Hepion Pharmaceuticals
Performance |
| Timeline |
| Kiora Pharmaceuticals |
| Hepion Pharmaceuticals |
Kiora Pharmaceuticals and Hepion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiora Pharmaceuticals and Hepion Pharmaceuticals
The main advantage of trading using opposite Kiora Pharmaceuticals and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiora Pharmaceuticals position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.| Kiora Pharmaceuticals vs. ZyVersa Therapeutics | Kiora Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Kiora Pharmaceuticals vs. Zura Bio Limited | Kiora Pharmaceuticals vs. Phio Pharmaceuticals Corp |
| Hepion Pharmaceuticals vs. Kiora Pharmaceuticals | Hepion Pharmaceuticals vs. ZyVersa Therapeutics | Hepion Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Hepion Pharmaceuticals vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |